The US Federal Trade Commission has joined two US states to seek an injunction blocking the merger of Edinburgh spinout FanDuel with DraftKings.
Pain assessment technology developer ePat is set to list on the Australian Stock Exchange today, providing an exit to Curtin University.
The news roundup for the week ending 24 June 2016.
Abingdon Health enters into a partnership with Sumitomo Chemical to build on the rapid diagnostic test platform developed by Sumitomo and Abingdon Health subsidiary Molecular Vision.
Queensland, Sydney, RMIT, South Australia and Curtin universities agree to a standardised approach to IP to increase the country's current OECD ranking.
Bath University spinout Atlas Genetics gains approval to sell its rapid chlamydia test within the EU.
The Securities and Exchange Commission (SEC) adopts crowdfunding rules after long wait.
Swansea spinout Bionema has received watchdog approval to test its biopesticides that could stop pests from destroying crops.